|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Osteoporosis Research Center, Creighton University, Omaha, NE (RPH and LAGA); the Departments of Pediatrics (BWH) and Medicine (JRS and NHB), Medical University of South Carolina, Charleston, SC; and the Department of Medicine, University of Wisconsin, Madison, WI (NB)
Background: Neither the efficiency of the 25-hydroxylation of vitamin D nor the steady state relation between vitamin D3 and 25-hydroxyvitamin D [25(OH)D] has been studied in humans.
Objective: We aimed to examine the relation between serum vitamin D3 and 25(OH)D in normal subjects after either oral administration of vitamin D3 or ultraviolet-B radiation across a broad range of inputs.
Design: Values for serum vitamin D3 and (OH)D3 were aggregated from 6 studies—1 acute and 5 near-steady state—at various vitamin D3 inputs. In 3 of the steady state studies, vitamin D3 had been administered for 18–26 wk in doses of 0 to 11000 IU/d; in 2 studies, subjects had received solar or ultraviolet-B irradiation.
Results: In the acute study, subjects receiving a single 100000-IU dose of vitamin D3 had a rise in serum cholecalciferol to a mean of 521 nmol/L at 1 d and then a fall to near-baseline values by 7–14 d. Serum 25(OH)D peaked at 103 nmol/L on day 7 and fell slowly to baseline by day 112. In the 5 steady state studies, the relation of serum 25(OH)D to serum vitamin D3 was biphasic and was well described by a combined exponential and linear function: Y = 0.433X + 87.81[1–exp (–0.468X)], with R2 = 0.448.
Conclusions: At physiologic inputs, there is rapid conversion of precursor to product at low vitamin D3 concentrations and a much slower rate of conversion at higher concentrations. These data suggest that, at typical vitamin D3 inputs and serum concentrations, there is very little native cholecalciferol in the body, and 25(OH)D constitutes the bulk of vitamin D reserves. However, at supraphysiologic inputs, large quantities of vitamin D3 are stored as the native compound, presumably in body fat, and are slowly released to be converted to 25(OH)D.
This article has been cited by other articles:
![]() |
K. D Cashman and M. Kiely Reply to R Vieth Am. J. Clinical Nutrition, October 1, 2009; 90(4): 1115 - 1116. [Full Text] [PDF] |
||||
![]() |
N. B. Khazai, S. E. Judd, L. Jeng, L. L. Wolfenden, A. Stecenko, T. R. Ziegler, and V. Tangpricha Treatment and Prevention of Vitamin D Insufficiency in Cystic Fibrosis Patients: Comparative Efficacy of Ergocalciferol, Cholecalciferol, and UV Light J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2037 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Ginde, J. M. Mansbach, and C. A. Camargo Jr Association Between Serum 25-Hydroxyvitamin D Level and Upper Respiratory Tract Infection in the Third National Health and Nutrition Examination Survey Arch Intern Med, February 23, 2009; 169(4): 384 - 390. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |